Search

Health related quality of life measures as outcome parameters in middle ear diseases

Surely the only outcome needed for post-surgical ears is a better PTA? Marcus Neudert argues there should be more to it than that. To draw a comprehensive picture of the disease-associated restrictions in patients with chronic otitis media, audiometric outcome...

Alternobaric vertigo: asymmetrical vestibular function due to asymmetrical middle ear pressures (Iron Man’s archenemy)

The Marvel Cinematic Universe could certainly be deemed an ‘extreme environment’ and yet very rarely do we see the Avenger’s popping to the clinic for a check-up. Hee-Young Kim has wondered how they cope with extreme pressure changes and discusses...

Specialist teams deliver world-class trauma care

University Hospitals Birmingham NHS Foundation Trust runs the Queen Elizabeth Hospital Birmingham, which is a designated Major Trauma Centre. The Trust holds the contract to treat all UK injured military personnel evacuated from combat zones overseas. More than 1200 of...

10 steps to improving transition to adult services

Children and parents like the reassurance that staying under the care of the team who looked after them from birth gives, but as the child approaches adulthood he / she must come under the care of a new team. This...

Will it ever happen?

Audiology is a rapidly evolving field, with many exciting developments on the horizon. David Baguley identified some topics of interest, and asked some international experts ‘will it ever happen?’ Gene therapy for deafness After years of development, gene therapy for...

In conversation with Reza Rahbar

Reza Rahbar is professor of otolaryngology at Harvard Medical School and associate otolaryngologist-in-chief at Boston Children’s Hospital. He initiated and leads IPOG, the International Pediatric Otolaryngology Group. I met up with him to ask more about it. Reza Rahbar DMD,...

Mind the gap – developing a sustainable pipeline for hearing therapeutics

In this article, the authors describe three key challenges faced in developing hearing therapeutics. Collaboration between companies, sectors and disciplines will be key to finding solutions. The unmet need for therapies for hearing loss grows apace, with prevalence rising across...

Early detection pathways for congenital cytomegalovirus for infants referred from the newborn hearing screen

This article discusses requirements for an early congenital cytomegalovirus (cCMV) detection pathway to ensure children do not miss out on the opportunity for timely diagnosis and treatment. The pathways described are currently in use in England and apply to well...